Evidence map›Paper›PMID 38667281›Full record

ReviewCells2024

Chromosome Transplantation: Opportunities and Limitations.

Angela La Grua, Ilaria Rao, Lucia Susani, Franco Lucchini, Elena Raimondi, Paolo Vezzoni, Marianna Paulis

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Angela La GruaDepartment of Medical Biotechnologies and Translational Medicine, University of Milan, 20129 Milan, Italy.
Ilaria RaoIRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.ORCID 0000-0003-2532-2957
Lucia SusaniIRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.ORCID 0000-0003-3368-2135
Franco LucchiniDepartment for Sustainable Food Process, Università Cattolica del Sacro Cuore, 29122 Piacenza, Italy.ORCID 0000-0003-0280-7062
Elena RaimondiDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.ORCID 0000-0001-6781-0137
Paolo VezzoniIRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.
Marianna PaulisIRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.ORCID 0000-0001-7803-9982
Institute of Genetic and Biomedical Research · ITHumanitas University · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Milan · ITUniversity of Pavia · IT

Funding

Ministero della Salute RF-2019-12369703
6 · The paper itself

Abstract

There are thousands of rare genetic diseases that could be treated with classical gene therapy strategies such as the addition of the defective gene via viral or non-viral delivery or by direct gene editing. However, several genetic defects are too complex for these approaches. These "genomic mutations" include aneuploidies, intra and inter chromosomal rearrangements, large deletions, or inversion and copy number variations. Chromosome transplantation (CT) refers to the precise substitution of an endogenous chromosome with an exogenous one. By the addition of an exogenous chromosome and the concomitant elimination of the endogenous one, every genetic defect, irrespective of its nature, could be resolved. In the current review, we analyze the state of the art of this technique and discuss its possible application to human pathology. CT might not be limited to the treatment of human diseases. By working on sex chromosomes, we showed that female cells can be obtained from male cells, since chromosome-transplanted cells can lose either sex chromosome, giving rise to 46,XY or 46,XX diploid cells, a modification that could be exploited to obtain female gametes from male cells. Moreover, CT could be used in veterinary biology, since entire chromosomes containing an advantageous locus could be transferred to animals of zootechnical interest without altering their specific genetic background and the need for long and complex interbreeding. CT could also be useful to rescue extinct species if only male cells were available. Finally, the generation of "synthetic" cells could be achieved by repeated CT into a recipient cell. CT is an additional tool for genetic modification of mammalian cells.

Indexed as

ChromosomesGenomic MedicineAnimalsFemaleGenetic TherapyHumansMaleSynthetic Biologychromosome transplantationDuchenne muscular dystrophygenomic diseaseiPSCX chromosome

Identifiers

PMID38667281
PMCPMC11048979
OpenAlexW4394725753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.